FDA  approved  Galafold (migalastat) as the first oral medication for the treatment of Fabry disease that is a rare genetic disorder.

Fabry disease is a rare and inherited genetic disorder  when a type of fat called Globotriaosylceramide is built (GL-3) in blood vessels, the kidneys, the heart, the nerves and other parts of the body & it affects both females & males.